Stable injectable pharmaceutical formulation for 1,4-...

Details Stable injectable pharmaceutical formulation for 1,4-... Stable injectable pharmaceutical formulation for 1,4-...

A - Human Necessities

61

K

167/277

A61K 31/135 (2006.01) A61K 47/02 (2006.01) A61K 47/18 (2006.01)

Patent

CA 1283607

ABSTRACT OF THE DISCLOSURE This disclosure describes stable injectable pharmaceutical formulations of NOVANTRONE?. This compound has the formula Image and is known as 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)- ethylamino]anthraquinone.

531200

Affiliated with

Also associated with

Rating

Stable injectable pharmaceutical formulation for 1,4-... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable injectable pharmaceutical formulation for 1,4-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable injectable pharmaceutical formulation for 1,4-... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1225233